Bactiguard joined license partner BD at leading healthcare conference in India, CRITICARE 2025. With healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) posing serious challenges in Indian intensive care units (ICU) the conference provided an important platform to engage with healthcare professionals and key opinion leaders on effective prevention strategies.
Infection prevention remains a significant challenge in India, particularly in critical care settings where the burden of HAIs is notably high.1 These infections substantially contribute to the country’s elevated AMR rates, posing serious threats to patient safety and public health. A study highlighted that the infection rate among ICU patients in India was found to around 53 percent.2
Additionally, the Centers for Disease Control and Prevention (CDC) has reported that bacteria causing common infections in India, such as urinary tract and bloodstream infections, are becoming resistant to nearly all antibiotics.3
With AMR rates rising and critical care settings particularly vulnerable, strengthening infection control measures is more urgent than ever. To raise further awareness on this critical issue, BD, with the support of Bactiguard, arranged the presentation of Key Opinion Leader, Dr. Dubey, in the main hall on Saturday afternoon. The session, titled “Revolutionizing CAUTI Management with Infection Control Foleys,” highlighted the impact of CAUTI and how Bactiguard’s infection prevention technology can make a difference. Attending CRITICARE marked an important first step in informing both users and key opinion leaders that BD will soon take over the sales and distribution of Bactiguard-coated catheters in India. With BD’s upcoming launch, more patients across India will gain access to Bactiguard’s infection prevention technology, improving safety and reducing the risk of device-related infections.
“AMR is a significant challenge in India, driven by the widespread and excessive use of antibiotics. At CRITICARE, one of the most important conversations was on the urgent need for effective infection prevention and control measures. Bactiguard-coated catheters are a very compelling narrative for an effective and safe solution to reduce catheter-associated urinary tract infections while promoting more sustainable antibiotic practices in this high-need market,” says Pankaj Malhotra, Chief Medical Officer at Bactiguard.
About CRITICARE 2025
CRITICARE is the annual flagship conference of the Indian Society of Critical Care Medicine (ISCCM), bringing together intensivists, anesthesiologists, emergency physicians, and other healthcare professionals dedicated to critical care. The event serves as a premier platform for knowledge exchange, hands-on training, and collaboration with global experts, featuring cutting-edge research, interactive workshops, and the latest advancements in intensive care medicine..
1 Gandra S, Vasudevan AK, Warren DK, Singh SK. Strengthening hospital epidemiology & infection prevention research capacity in India to curb antimicrobial resistance. Indian J Med Res. 2024 Jan 1;159(1):7-9. doi: 10.4103/ijmr.ijmr_1919_23. Epub 2024 Mar 4. PMID: 38344922; PMCID: PMC10954105.
2 Gautam G, Satija S, Kaur R, Kumar A, Sharma D, Dhakad MS. Insight into the Burden of Antimicrobial Resistance among Bacterial Pathogens Isolated from Patients Admitted in ICUs of a Tertiary Care Hospital in India. Can J Infect Dis Med Microbiol. 2024 Jan 6;2024:7403044. doi: 10.1155/2024/7403044. PMID: 38223353; PMCID: PMC10787651.
3 CDC Antibiotic Resistance in India https://archive.cdc.gov/www_cdc_gov/ncezid/stories-features/global-stories/ar-india.html